NEW YORK, Nov. 28, 2017 /PRNewswire/ -- OTC Markets
Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000
U.S. and global securities, today announced Nuvo Pharmaceuticals
Inc (TSX: NRI; OTCQX: NRIFF), a commercial healthcare company, has
qualified to trade on OTCQX® Best Market. Nuvo
Pharmaceuticals upgraded to OTCQX from the Pink® market.
Nuvo Pharmaceuticals begins trading today on OTCQX under the
symbol "NRIFF." U.S. investors can find current financial
disclosure and Real-Time Level 2 quotes for the company on
www.otcmarkets.com.
"Nuvo Pharmaceuticals joins over 100 Canadian companies together
representing $30 billion in market
capitalization that cross-trade their shares on our OTCQX Best
Market," said Jason Paltrowitz,
Executive Vice President of OTC Markets Group. "OTCQX enables
international companies to efficiently provide U.S. investors with
transparent trading and convenient access to their news and
financials. We look forward to supporting Nuvo Pharmaceuticals in
the U.S. public market."
"Upgrading to OTCQX is an important milestone for the Company,
and puts Nuvo Pharmaceuticals Inc. in the same market as many
esteemed global companies. The enhanced visibility and
greater exposure to US retail and institutional investors resulting
from the OTCQX market is part of our strategy to expand our
shareholder base and increase shareholder value," said Jesse Ledger, President and CEO of Nuvo
Pharmaceuticals Inc.
Nuvo Pharmaceuticals was sponsored for OTCQX by Troutman Sanders
LLP, a qualified third-party firm responsible for providing
guidance on OTCQX requirements and recommending
membership.
About Nuvo Pharmaceuticals Inc
Nuvo is a commercial
healthcare company with a portfolio of commercial products and
pharmaceutical manufacturing capabilities. Nuvo has three
commercial products that are available in a number of countries;
Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine patch.
Pennsaid 2% is sold in the U.S. by Horizon Pharma plc and is
available for partnering in certain other territories around the
world. Nuvo manufactures Pennsaid for the global market and
Pennsaid 2% for the U.S. market at its FDA, Health Canada and E.U.
approved manufacturing facility in Varennes, Québec.
About OTC Markets Group Inc.
OTC Markets Group Inc.
(OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture
Market, and the Pink® Open Market for 10,000 U.S. and global
securities. Through OTC Link® ATS, we connect a diverse
network of broker-dealers that provide liquidity and execution
services. We enable investors to easily trade through the
broker of their choice and empower companies to improve the quality
of information available for investors.
To learn more about how we create better informed and more
efficient markets, visit www.otcmarkets.com
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and
SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212)
896-4428, media@otcmarkets.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/otc-markets-group-welcomes-nuvo-pharmaceuticals-to-otcqx-300561914.html
SOURCE OTC Markets Group Inc.